重组抗小鼠CD28单抗(PV-1) | Syd Labs PA007463.m2a

重组抗小鼠CD28单抗(PV-1) Syd Labs PA007463.m2a - 武汉多找找科技

重组抗小鼠CD28单抗(PV-1) | Syd Labs PA007463.m2a

In stock

一键复制

Syd Labs体内实验级重组抗小鼠CD28单抗(克隆号PV-1,货号:PA007463.m2a),小鼠IgG2a kappa 是用哺乳动物细胞生产的重组抗体,适用于体外和体内研究,纯度>95%。其不变区为小鼠Mouse IgG2a Kappa (mIgG2a或m2a),可与重组小鼠IgG2a同型对照抗体配套使用。样品制备条件和最佳样品稀释度应由研究人员通过实验确定。

产品参数

货号 PA007463.m2a
产品名称重组抗小鼠CD28单抗(PV-1) | Syd Labs PA007463.m2a
英文名 In vivo Grade Recombinant Anti-Mouse CD28 Monoclonal Antibody, Mouse IgG2a Kappa (Clone: PV-1)
供货商名称 Syd Labs, Inc.
品牌名 Syd Labs
别称 T 细胞特异性表面糖蛋白 CD28,TP44
概述 Syd Labs提供重组小鼠IgG2a同型对照抗体。样品制备条件和最佳样品稀释应由研究人员通过实验确定。
克隆号 PV-1
同种型 小鼠IgG2a kappa
应用 ELISA、流式细胞术、中和、功能测定,如生物分析PK和ADA测定,以及用于研究受小鼠CD28蛋白影响的生物途径的测定。
免疫源 体内实验级重组抗小鼠CD28单克隆抗体(克隆:PV-1)在哺乳动物细胞中产生
抗体形式 0.2 μM过滤溶液,1x PBS
内毒素 根据 LAL 方法,≤1 EU每1mg 蛋白质
纯度 >95%(在还原条件下通过SDS-PAGE测定)
运输 体内实验级重组抗小鼠CD28单克隆抗体,小鼠IgG2a kappa(克隆号PV-1) 用冰袋运输。收到后,请立即将其存放在下面建议的温度下。
稳定性与存储 使用手动除霜冰箱并避免重复冻融循环。 自收到之日起 1 个月,保存在2 至 8°C。 自收到之日起12个月,保存在-20 至 -70°C。
注意事项 PA007463.m2a Syd Labs提供重组小鼠IgG2a同型对照抗体。样品制备条件和最佳样品稀释应由研究人员通过实验确定。
产品咨询 Syd Labs在国内只通过代理商销售其产品,不做直销。终端用户咨询价格请联系Syd Labs中国代理商。
关于Syd Labs产品如果有任何技术或其它问题,欢迎随时联系Syd Labs国内市场推广合作伙伴:武汉多找找科技有限公司,企业微信:duozhaozhao2024 联系电话:18162581039(龙经理)
应用详情 ELISA、流式细胞术、中和、功能测定,如生物分析PK和ADA测定,以及用于研究受小鼠CD28蛋白影响的生物途径的测定。

文献

PA007463.m2a:抗小鼠CD28单克隆抗体(克隆号PV-1),体内实验级重组,小鼠IgG2a kappa(In vivo Grade Recombinant Anti-Mouse CD28 Monoclonal Antibody, Mouse IgG2a Kappa (Clone: PV-1)

体内实验级重组抗小鼠CD28单克隆抗体(克隆号PV-1,小鼠IgG2a kappa)是一种针对小鼠CD28分子的激活性重组抗体。CD28主要表达于T细胞表面,是介导T细胞完整活化极其关键的共刺激受体(第二信号受体)。通过与天然配体CD80(B7-1)和CD86(B7-2)结合,CD28可协同T细胞受体(TCR,第一信号)信号通路,强效诱导T细胞克隆增殖、细胞因子(如IL-2)分泌并阻止细胞凋亡。作为经典的共刺激激动剂,抗小鼠CD28单抗(PV-1克隆)能够特异性结合小鼠CD28分子,常与抗CD3单抗配套使用,在体外T细胞扩增及体内免疫功能调控实验中发挥关键作用。

作为高品质的体内实验级重组抗小鼠CD28单克隆抗体(PV-1克隆,小鼠IgG2a kappa),该产品采用小鼠IgG2a格式并由哺乳动物细胞重组表达精制而成,具备超低内毒素、无叠氮化物及无外源载体蛋白的优势,可最大程度避免非特异性免疫干扰与体内毒性。小鼠IgG2a格式使其在同种小鼠模型中具备优异的免疫兼容性,并可配套重组小鼠IgG2a同型对照抗体进行严谨的对照分析。该抗体广泛应用于小鼠T细胞活化与分化、肿瘤免疫治疗机制、自身免疫性疾病模型以及过继性细胞免疫治疗等前沿体内外研究。

抗小鼠 CD28 单克隆抗体参考文献:

1. CXCL13 antibody for the treatment of autoimmune disorders

Klimatcheva, E., et al. BMC Immunol. 2015 Feb 12;16(1):6. PMID: 25879435

“The cells were incubated at 37°C for 4 days after which the cells were collected, washed and cultured in media containing 2 μg/ml of each anti-muCD3e and anti-muCD28 antibody for 3 days. For the adoptive transfer, the mice were injected i.p. with 2×10⁶ cells in 100 μl PBS. …Antibodies: …anti-murine CD3e (clone 145-2C11; BioXcell; BE0001-1); anti-murine CD28 (clone PV-1; BioXcell; BE0015-5); anti-murine IFN-γ (clone XMG1.2; BioXcell; BE0055).”

2. IL-27 and IL-12 oppose pro-inflammatory IL-23 in CD4+ T cells by inducing Blimp1

Heinemann, C., et al. Nat Commun. 2014 May 6;5:3770. PMID: 24796719

“Naive CD4+ T cells were polyclonally stimulated for 3 days with plate-bound antibody to CD3 and soluble antibody to CD28 in the absence of exogenous cytokines (Th0), or differentiated into Tr-1 cells (100 ng ml⁻¹ IL-27 plus 0.5 ng ml⁻¹ TGF-β) or Th17 cells (50 ng ml⁻¹ IL-6 plus 0.5 ng ml⁻¹ TGF-β) for microarray analysis. …For in vitro T-cell differentiation, magnetic bead-purified CD4+CD62L+ or flow cytometrically purified CD4+CD44⁻CD25⁻ T cells were stimulated for 3 days with 4 μg ml⁻¹ plate-bound antibody to CD3 (BioXcell, 145-2C11) and 2 μg ml⁻¹ soluble antibody to CD28 (BioXcell, PV-1).”

3. Ezrin and moesin are required for efficient T cell adhesion and homing to lymphoid organs

Chen, E. J. H., et al. PLoS One. 2013 Feb 28;8(2):e52368. PMID: 23468835

“T cells were stimulated in 24-well plates coated with 1 μg/mL anti-CD28 (PV1) and anti-CD3 (2C11) (both from BioXCell) for three days and maintained in DMEM supplemented with 5% FBS, penicillin, streptomycin, glutaMAX, Hepes, NEAA and β-mercaptoethanol at 37°C, 10% CO2. …To produce ezrin and/or moesin deficient murine CD4+ T cell blasts, freshly isolated ezrinflox/flox or ezrinflox/flox:CD4cre T cells were stimulated as described above and removed from stimulation for two days.”

4. IL-9 as a mediator of Th17-driven inflammatory disease

Nowak, E. C., et al. J Exp Med. 2009 Aug 3;206(8):1653-60. PMID: 19596803

“Th17 cells were generated with 2.5 ng/ml TGF-β, 20 ng/ml IL-6, 10 μg/ml αIFN-γ, and 10 μg/ml αIL-4 using 5 μg/ml of plate-bound CD3 (145-2C11; BioXCell) and CD28 (PV-1; BioXCell), respectively. …Cells were washed, counted, and restimulated in the presence of αCD3/αCD28 for 24 h before supernatants were collected for ELISA.”

Syd Labs抗小鼠CD28单克隆抗体(克隆号PV-1),小鼠IgG2a kappa(货号:PA007463.m2a)推荐同型对照抗体:

重组小鼠IgG2a同型对照抗体